CYCC icon

Cyclacel Pharmaceuticals
CYCC

Overview Fund Activity

26 hedge funds and large institutions have $3.4M invested in Cyclacel Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 5 closing their positions.

Holders
26
Holders Change
+4
Holders Change %
+18.18%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
8
Reduced
4
Closed
5
Calls
$17K
Puts
$5K
Net Calls
+$12K
Net Calls Change
-$139K

Top Buyers

1
Acadian Asset Management
1
Acadian Asset Management
Massachusetts
$535K
2
SFM
2
Sphera Funds Management
Israel
$365K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$245K
4
SSA
4
Schonfeld Strategic Advisors
New York
$898K
5
Millennium Management
5
Millennium Management
New York
$285K

Top Sellers

1
SCM
1
Sio Capital Management
New York
$0
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$250K
3
IC
3
Ikarian Capital
Texas
$0
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$0
5
VF
5
Virtu Financial
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
SCM
26
Sio Capital Management
New York
– – -454,355 Closed
IC
27
Ikarian Capital
Texas
– – -104,741 Closed
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
– – -31,519 Closed
VF
29
Virtu Financial
New York
– – -30,616 Closed
Citigroup
30
Citigroup
New York
– – -563 Closed
Citadel Advisors
31
Citadel Advisors
Florida
– – – –
CFGS
32
Concourse Financial Group Securities
Alabama
– – – –
S
33
SignatureFD
Georgia
$0 300 – –
Wolverine Trading
34
Wolverine Trading
Illinois
– – – –
1
2